SV2B (synaptic vesicle glycoprotein 2B)

2014-08-01  

Identity

HGNC
LOCATION
15q26.1
LOCUSID
ALIAS
HsT19680
FUSION GENES

Other Information

Locus ID:

NCBI: 9899
MIM: 185861
HGNC: 16874
Ensembl: ENSG00000185518

Variants:

dbSNP: 9899
ClinVar: 9899
TCGA: ENSG00000185518
COSMIC: SV2B

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000185518ENST00000330276Q7L1I2
ENSG00000185518ENST00000394232Q7L1I2
ENSG00000185518ENST00000545111Q7L1I2
ENSG00000185518ENST00000557410Q7L1I2

Expression (GTEx)

0
10
20
30
40
50
60
70
80

Pathways

PathwaySourceExternal ID
ECM-receptor interactionKEGGko04512
ECM-receptor interactionKEGGhsa04512
DiseaseREACTOMER-HSA-1643685
Infectious diseaseREACTOMER-HSA-5663205
Uptake and actions of bacterial toxinsREACTOMER-HSA-5339562
Neurotoxicity of clostridium toxinsREACTOMER-HSA-168799
Toxicity of botulinum toxin type A (BoNT/A)REACTOMER-HSA-5250968
Toxicity of botulinum toxin type E (BoNT/E)REACTOMER-HSA-5250992
Toxicity of botulinum toxin type D (BoNT/D)REACTOMER-HSA-5250955
Toxicity of botulinum toxin type F (BoNT/F)REACTOMER-HSA-5250981

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
335887522021Differentiation of two human neuroblastoma cell lines alters SV2 expression patterns.3
335887522021Differentiation of two human neuroblastoma cell lines alters SV2 expression patterns.3
326670332020Bioinformatics analysis of potential core genes for glioblastoma.7
326670332020Bioinformatics analysis of potential core genes for glioblastoma.7
236178382014Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis.29
236178382014Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis.29
203796142010Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.78
206280862010Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.15
203796142010Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.78
206280862010Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.15
189771202009No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy.8
199131212009Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.105
189771202009No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy.8
199131212009Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.105
183671542008Linkage disequilibrium mapping of a chromosome 15q25-26 major depression linkage region and sequencing of NTRK3.16

Citation

Dessen P

SV2B (synaptic vesicle glycoprotein 2B)

Atlas Genet Cytogenet Oncol Haematol. 2014-08-01

Online version: http://atlasgeneticsoncology.org/gene/54677/sv2b-(synaptic-vesicle-glycoprotein-2b)